Top Biotech Companies To Buy For 2016

Top Biotech Companies To Buy For 2016: Gilead Sciences Inc.(GILD)

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 73! 40, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fos t er City, California.

Advisors' Opinion:

• [By Matt Egan]

  The real stars will come later when health care companies report their quarterly results. Thanks to blockbuster growth from biotech companies like Gilead Sciences (GILD), the health care industry is projected to increase profits by a hefty 19% from the year before.

• [By Ben Levisohn]

  Just weeks after AbbVie (ABBV) struck a deal to make its hepatitis-C treatment the only one approved by Express Scripts (ESRX), Gilead Sciences (GILD) has reached a similar deal with CVS (CVS). Citigroup’s Yaron Werber explains the significance:

source from Top Stocks For 2015:http://www.topstocksblog.com/top-biotech-companies-to-buy-for-2016.html

Best High Tech Companies To Invest In Right Now

Best High Tech Companies To Invest In Right Now: Open Text Corporation (OTEX)

Open Text Corporation develops, markets, sells, licenses, and supports enterprise content management (ECM) solutions primarily in North America and Europe. The company?s ECM software and solutions enable customers to manage various types of enterprise content, including business documents, Web content, records, digital assets, email, forms and reports, forums, blogs, wikis, and real time instant messaging and collaboration. Its ECM solutions comprise various components, including document management, which provides repository for business documents, such as Microsoft office, CAD, and PDF; collaboration that offers tools designed to better facilitate people working with each other with content and processes; Web content management, which provides tools for authoring, maintaining, and administering sophisticated Web sites; and records management that enables control of the lifecycle of content objects by associating robust retention and disposition rules with each content as set. The company?s ECM solutions also provide email management services designed to enable the archiving, control, and monitoring of email; capture and delivery tools that provide the means of converting documents from analog sources; digital asset management; business process management services; content reporting tools for analyzing content and generating reports; and Open Text Everywhere that allows the Open Text ECM suite to be available via mobile devices. In addition, it offers industry specific solutions for government, technology/manufacturing, energy, financial services, pharmaceutical and life sciences, legal, and media sectors. Additionally, the company provides learning, consulting, hosting, and customer support and training services. It has strategic alliances with Microsoft Corporation, Oracle Corporation, and SAP AG. The company was founded in 1991 and is headquartered in Waterloo, Canada.

Advisors' Opinion:

[By Jake L'Ecuyer]

Shares of Open Text (NASDAQ: OTEX) got a boost, shooting up 12.23percent to $101.70 after the company reported upbeat Q2 results and announced a 2-for-1 stock split.

• [By Jake L'Ecuyer]

  Shares of Open Text (NASDAQ: OTEX) got a boost, shooting up 11.95 percent to $101.45 after the company reported upbeat Q2 results and announced a 2-for-1 stock split.

• [By Michael Robinson]

  Open Text (OTEX)

  Known as one of the world's leading data management firms for large organizations, Open Text ranks as the biggest software company in Canada. A roster of A-list clients helps a great deal. Some of Open Text's stable of blue-chip clients include Coca-Cola, BP, and Visa.

• [By Robert Abbott]

  OpenText Corporation (OTEX) fits within the latter group. Since its inception as a search engine-type company in 1991, it has become something of a giant itself. It operates in the Enterprise Information Management industry, with annual revenue of more than $1.6 billion and capable of going head-to-head with names such as IBM(IBM) and Hewlett Packard(HPQ).

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-high-tech-companies-to-invest-in-right-now.html

Top 10 Healthcare Equipment Stocks To Watch Right Now

Top 10 Healthcare Equipment Stocks To Watch Right Now: Sao Martinho SA (SMTO3)

Sao Martinho SA is a Brazil-based holding company primarily engaged in the sale and production of sugar and ethanol. It is engaged in the cultivation of sugar cane and production and sale of sugar, ethanol and other sugar cane products. The Company is also involved in the cogeneration of electricity and cattle breeding, as well as the provision of agricultural products. The Company produces hydrous ethanol, anhydrous ethanol, industrial ethanol, ribonucleic acid, fuel oil, yeast, sugar and sugarcane biogases, used to generate steam and electricity. Through its subsidiary Omtek, the Company produces ribonucleic acid (RNA) sodium salt, which is used in the pharmaceutical and food industries as a raw material and flavor enhancer. The Company operates through a numerous subsidiaries, including Vale do Mogi Empreendimentos Imobiliarios SA, SMA Industria Quimica SA, Usina Santa Luiza SA, Sao Martinho Energia SA and Santa Cruz SA, among others. Advisors' Opinion:

• [By Ney Hayashi]

  Sugar and ethanol producer Sao Martinho SA (SMTO3) fell 1.8 percent to 25.53 reais after posting a quarterly profit that missed analysts' estimates.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-healthcare-equipment-stocks-to-watch-right-now-3.html